Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sanofi SA Announces CE Mark for Its JuniorSTAR Halfunit Insulin Reusable Pen

Thursday, 26 Sep 2013 01:01am EDT 

Sanofi SA announced the CE Mark of its JuniorSTAR, a new halfunit insulin reusable pen that can be used with Lantus (insulin glargine), Apidra (insulin glulisine) or Insuman (recombinant human insulin). Delivering from 1 to 30 units per injection, JuniorSTAR is an easy-to-use lightweight pen with a large dose display and a single-step dial back that does not leak insulin. JuniorSTAR has been developed and is manufactured by Sanofi SA's partner Haselmeier GmbH, Stuttgart, Germany. 

Company Quote

1 Apr 2015